Results 121 to 130 of about 114,860,682 (209)

Lobular carcinoma in situ: Incidence and treatment [PDF]

Cancer, 1973
J M, Giordano, C T, Klopp
openaire   +2 more sources

Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.

, 2003
Lobular neoplasia (LN), including atypical lobular hyperplasia (ALH) and lobular carcinoma in situ, may be encountered in breast core biopsies performed for mammographic abnormalities even though LN is often not, in itself, responsible for the abnormal ...
Crisi, Giovanna, MD
core   +1 more source

Florid Lobular Carcinoma In Situ (F-LCIS) Showing Predominantly Hypoechoic Masses With Obscured Margins and No Attenuated Posterior Echoes on Ultrasound: A Case Report. [PDF]

Cureus
Arizumi K, Oura S.
europepmc   +1 more source

American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications. [PDF]

Ann Diagn Pathol, 2020
Schnitt SJ, Brogi E, Chen YY, King TA, Lakhani SR.   +4 more
europepmc   +1 more source

Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast. [PDF]

Breast Cancer Res Treat
Kaur M, Quirarte A, Vertido A, Torosian T, Li TM, Mouabbi JA, Mukhtar RA.   +6 more
europepmc   +1 more source

NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS). [PDF]

Histopathology
Christgen M, Bartels S, Kreipe H.
europepmc   +1 more source

Clinical Outcomes of Lobular Carcinoma <i>In Situ</i>: Risk of Invasive Cancer Development. [PDF]

J Breast Cancer
Woen D, Kim KJ, Lee SM, Lee S, Oh K, Lee CE, Nam SJ, Kim SW, Lee JE, Chae BJ, Lee SK, Ryu JM, Park WK, Lee H, Yu J.   +14 more
europepmc   +1 more source

Breast conserving surgery in the management of in situ breast carcinoma

, 1991
In a retrospective review of 73 patients with in situ breast carcinoma seen in the Combined Breast Clinic at the Royal Marsden and St. George's Hospitals between 1969 and 1988, 20 (27%) were found to have in situ lobular and 53 (73%) in situ intraduct ...
Lakhani, S., Graham, M. D., Gazet, J. C.
core  

Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β

, 2018
Transcription factor AP-2β (TFAP2B) regulates embryonic organ development and is overexpressed in alveolar rhabdomyosarcoma, a rare childhood malignancy. Gene expression profiling has implicated AP-2β in breast cancer (BC). This study characterizes AP-2β
Gronewold, Malte, Kreipe, Hans H., Glage, Silke, Derksen, Patrick W., Gluz, Oleg, Lehmann, Ulrich, Boelens, Mirjam, Christgen, Henriette, Kates, Ronald, Bentires-Alj, Mohammad, Christgen, Matthias, Kuehnle, Elna, Feuerhake, Friedrich, Raap, Mieke, Harbeck, Nadia, Jonkers, Jos, Koren, Shany, Nitz, Ulrike   +17 more
core  

Lobular carcinoma in situ detectable as a mass on ultrasonography: a case report. [PDF]

J Med Ultrason (2001)
Kawanishi K, Okuno T, Sakakibara Y, Odani K, Asai S, Kohno Y, Kuwata Y.   +6 more
europepmc   +1 more source